Preferences for the administration of testosterone gel: evidence from a discrete choice experiment
Open Access
- 1 May 2019
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 13, 657-664
Abstract
Objectives: Differences in testosterone replacement therapy (TRT) gel products may affect patient satisfaction, quality-of-life, and treatment response and adherence. This study investigated preferences for TRT gel in terms of formulation and administration. Methods: 525 male adults aged 45 years and over completed a discrete choice experiment. Respondents made repeated choices between two hypothetical testosterone gel treatments described according to four attributes: form, ease of use, impact of use on showering/swimming, and location/dosage of the application. Choice data were analyzed using a latent class model. Results: Three preference classes were identified. Respondents across all classes displayed a preference for the gel being dispensed in smaller units with accurate dosing, waiting shorter times after the gel application before swimming/showering, and using 2.5 gm of gel to be applied to the inner thigh/abdomen as opposed 5 gm to shoulder/abdomen. The importance of these characteristics differed across classes, with preference class membership predicted by age and education level. For instance, younger men (aged 45–64 years) were more likely to belong to a class that prioritized reduced waiting time before being able to undertake activities. Formulation was not an important driver of choice. Conclusions: Preferences demonstrate a predilection for TRT gel dispensed in small units allowing precise dosing, shorter waiting time after application, and application to the inner thigh/abdomen. However, the strength of importance of these characteristics differs between men. This study highlights the attributes of TRT gel considered important to patient subgroups, and which may ultimately affect treatment response, medication adherence, and patient quality-of-life.Keywords
This publication has 13 references indexed in Scilit:
- A new 2% testosterone gel formulation: a comparison with currently available topical preparationsAndrology, 2018
- Late-Onset Hypogonadism and Mortality in Aging MenThe Journal of Clinical Endocrinology & Metabolism, 2014
- Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trialsAsian Journal of Andrology, 2014
- Beyond the male sex hormone: deciphering the metabolic and vascular actions of testosteroneJournal of Endocrinology, 2013
- Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? TrialPLOS ONE, 2013
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA RecommendationsJournal of Andrology, 2009
- A novel metered-dose 2% testosterone gel treatment for male hypogonadismThe Journal of Men's Health & Gender, 2007
- Testosterone and men's quality of lifeThe Aging Male, 2006
- Quick and easy choice sets: Constructing optimal and nearly optimal stated choice experimentsInternational Journal of Research in Marketing, 2005
- Sex hormones, inflammation and the metabolic syndrome: a population-based studyEuropean Journal of Endocrinology, 2003